or

search:

Methamphetamine 1 2


Methamphetamine is a powerful stimulant that activates certain systems in the brain. It is closely related chemically to amphetamine, but the central nervous system effects of methamphetamine are greater. Both drugs have some medical uses, primarily in the treatment of obesity, but their therapeutic use is limited. The central nervous system (CNS) actions that result from taking even small amounts of methamphetamine include increased wakefulness, increased physical activity, decreased appetite, increased respiration, hypethermia, and euphoria. Other CNS effects include irritability, insomnia, confusion, tremors, convulsions, anxiety, paranoia, and aggressiveness. Hyperthermia and convulsions can result in death.

Illicit methamphetamine, which is almost exclusively methamphetamine hydrochloride, is sold in powder, ice, and tablet forms. Powder methamphetamine, the most common form available in the United States, is produced domestically and also is smuggled into the country from Mexico. Traditionally, Asian-produced ice was almost exclusively found in Guam, Hawaii, and parts of California; however, increased domestic production of this form of methamphetamine has increased availability to several other areas of the country previously untouched by exposure to ice. Methamphetamine tablets, primarily manufactured in Burma, have been smuggled into the United States, especially to northern California and the Los Angeles area.

Source: DEA, "Drug Intelligence Brief: The Forms of Methamphetamine," April 2002


 

 

 


Methamphetamine Labs

Amphetamine

Stimulants

 



 


State Estimates of Past Year Methamphetamine Use
(The NSDUH Report, Issue 37, 2006)

Methamphetamine/Amphetamine Treatment Admissions in Urban and Rural Areas: 2004
(The DASIS Report, Issue 27, 2006)

Methamphetamine Use, Abuse, and Dependence: 2002, 2003, and 2004
(The NSDUH Report, September 16, 2005)

Methamphetamine
(NIDA InfoFacts, May 2005)

The NSDUH Report: Stimulant Use, 2003
(February 4, 2005)

Smoked Methamphetamine/Amphetamines: 1992-2002
(The DASIS Report, January 7, 2005)

 

 


Primary Methamphetamine and Amphetamine Treatment Admissions: 1993-2003
(The DASIS Report, Issue 9, 2006)

Amphetamine and Methamphetamine Emergency Department Visits, 1995-2002
(The DAWN Report, July 2004)

The DASIS Report: Characteristics of Primary Amphetamine Treatment Admissions: 2001
(SAMHSA, April 16, 2004)

The DASIS Report: Characteristics of Primary Amphetamine Treatment Admissions: 2001
(SAMHSA, April 16, 2004)

Methamphetamine
(ONDCP Fact Sheet, November 2003)

Methamphetamine Abuse and Addiction
(NIDA Research Report, January 2002)